Myocardial microthrombi after COVID-19 mRNA vaccination
Eur Heart J
.
2021 Nov 14;42(43):4501.
doi: 10.1093/eurheartj/ehab727.
Authors
Tadao Aikawa
1
2
,
Jiro Ogino
3
,
Yuichi Kita
4
,
Naohiro Funayama
1
Affiliations
1
Department of Cardiology, Hokkaido Cardiovascular Hospital, 1-30, Minami-27, Nishi-13, Chuo-ku, Sapporo 064-8622, Japan.
2
Department of Radiology, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-cho, Omiya-ku, Saitama 330-8503, Japan.
3
Department of Pathology, JR Sapporo Hospital, Kita-3, Higashi-1, Sapporo 060-0033, Japan.
4
Department of Radiology, Hokkaido Cardiovascular Hospital, 1-30, Minami-27, Nishi-13, Chuo-ku, Sapporo 064-8622, Japan.
PMID:
36282722
DOI:
10.1093/eurheartj/ehab727
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19* / prevention & control
Humans
Myocardium
RNA, Messenger
Thrombosis*
Vaccination
Substances
RNA, Messenger